Structural instability of the superficial layers of the fibrinogen matrix contributes to its nonadhesive properties
Source abstract
Abstract
Adsorption of fibrinogen on various surfaces, including biomaterials, significantly reduces adhesion of leukocytes and platelets. The mechanism by which fibrinogen renders surfaces nonadhesive involves its surface-induced self-assembly, resulting in the formation of a nanoscale multilayer matrix. Under static conditions, when tensile forces exerted by cellular integrins pull on the fibrinogen multilayer, it extends due to the separation of layers, preventing efficient mechanotransduction and leading to weak intracellular signaling and cell adhesion. Furthermore, a weak association between fibrinogen molecules in the superficial layers of the matrix allows integrins to pull fibrinogen molecules out of the matrix, causing the detachment of adherent cells. It remains unclear whether this process contributes to the anti-adhesive mechanism under flow when cells transiently contact the fibrinogen matrix. In the present study, using several flow systems, we demonstrated that various cells, including isolated blood cells, strip superficial fibrinogen molecules from the matrix, preventing their adhesion. Fibrinogen desorption in a cell-free buffer was significantly lower than that with cells. Surprisingly, the integrin fibrinogen receptors on cultured and primary leukocytes and platelets had minimal impact on fibrinogen detachment, as function-blocking anti-integrin antibodies did not significantly inhibit this process. Additionally, erythrocytes, which are not known to express specific fibrinogen receptors and even naked liposomes that can interact with fibrinogen with minimal affinity, caused fibrinogen detachment, suggesting that the stripping of superficial layers may arise from the low-affinity interactions of cells with the matrix. These results indicate that the peeling effect on the fibrinogen matrix exerted by cells under flow contributes to the anti-adhesive mechanism. STATEMENT OF SIGNIFICANCE: Adsorption of the blood protein fibrinogen on implanted vascular grafts is crucial for their clinical performance. Recent research shows that fibrinogen adsorption triggers its self-assembly, forming a nonadhesive multilayer matrix. The nonadhesive properties of this matrix under static conditions arise from layer separation, which occurs when cellular integrins pull on the matrix, reducing the mechanotransduction response and weakening cell adhesion. In this study, we reveal a new mechanism explaining why fibrinogen multilayer fails to support cell adhesion under flow. We demonstrate that flowing cells detach fibrinogen molecules that are loosely associated with the upper surface of the matrix, thereby preventing platelet and leukocyte adhesion. This work enhances our understanding of protective anti-adhesive mechanisms that the host develops after the implantation of biomaterials, which could inform the design of improved vascular grafts.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Blood properties and coagulation · Rheology and Fluid Dynamics Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia10.1182/blood.V55.2.169.169 ↗
2. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces?10.1182/blood.V68.2.355.355 ↗
3. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets10.1016/S0021-9258(18)99152-0 ↗
4. Human plasma fibrinogen adsorption and platelet adhesion to polysterene10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9 ↗
5. The role of adsorbed fibrinogen in platelet adhesion to polyurethane surfaces: a comparison of surface hydrophobicity, protein adsorption, monoclonal antibody binding, and platelet adhesion10.1002/jbm.a.30381 ↗
6. Anti-adhesive effect of fibrinogen: a safeguard for thrombus stability10.1182/blood-2006-05-022764 ↗
7. The relationship between platelet adhesion on surfaces and the structure versus the amount of adsorbed fibrinogen10.1016/j.biomaterials.2009.10.008 ↗
8. Influence of titanium nanoscale surface roughness on fibrinogen and albumin protein adsorption kinetics and platelet responses10.1002/jbm.a.37635 ↗
9. Revisiting the Vroman effect: mechanisms of competitive protein exchange on surfaces10.1016/j.colsurfb.2025.114927 ↗
10. Competitive adsorption and functional activity of fibrinogen on polyurethane biomaterials surfaces10.1116/6.0004598 ↗
11. Prostethic vascular grafts: wrong models. Wrong questions and no healing10.1016/j.biomaterials.2007.07.017 ↗
12. Control of integrin αIIbβ3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates10.1021/bi9016022 ↗
13. Origin of nonadhesive properties of fibrinogen matrices probed by force spectroscopy10.1021/la101791r ↗
14. The assembly of nonadhesive fibrinogen matrices depends on the αc regions of the fibrinogen molecule10.1074/jbc.M112.410696 ↗
15. Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating10.1016/j.biomaterials.2015.07.007 ↗
16. Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion10.1016/j.thromres.2015.10.001 ↗
17. Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading10.1055/s-0037-1615072 ↗
18. Regulated unmasking of the cryptic binding site for integrin αMβ2 in the γc-domain of fibrinogen10.1021/bi026324c ↗
19. Combined single cell AFM manipulation and TIRFM for probing the molecular stability of multilayer fibrinogen matrices10.1016/j.ultramic.2013.10.009 ↗
20. Latrotoxin-induced fusion of liposomes with bilayer phospholipid membranes10.1016/0005-2736(87)90345-2 ↗
21. A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity10.1074/jbc.M208877200 ↗
22. The interplay between integrins αMβ2 and α5β1 during cell migration to fibronectin10.1016/S0014-4827(02)00024-1 ↗
23. Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa10.1016/S0021-9258(19)36896-6 ↗
24. Plasminogen on the surface of fibrin clot prevents adhesion of leukocytes and platelets10.1111/j.1538-7836.2010.03778.x ↗
25. Effect of curvature on displacement forces acting on aortic endografts: a 3-dimensional computational analysis10.1583/08-2667.1 ↗
26. Comparison of straight and Venaflo-type cuffed arteriovenous ePTFE grafts in an animal study10.1016/j.jvs.2011.01.061 ↗
27. The CIS association of CD47 with integrin Mac-1 regulates macrophage responses by stabilizing the extended integrin conformation10.1016/j.jbc.2023.103024 ↗
28. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions10.1182/blood.V99.12.4457 ↗
29. Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-110.1074/jbc.M116.773713 ↗
30. Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2 , CR3) acts as a functional receptor for platelet factor 410.1074/jbc.RA117.000515 ↗
31. The binding of fibrinogen to its platelet receptor10.1016/S0021-9258(18)33645-7 ↗
32. The binding of fibrinogen and fibrinogen degradation products to the erythrocyte membrane and its relationship to haemorheology
33. Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule10.1016/0005-2736(87)90089-7 ↗
34. Involvement of fibrinogen specific binding in erythrocyte aggregation10.1016/S0014-5793(02)02575-9 ↗
35. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes10.1021/nn1009648 ↗
36. The (95)RGD(97) sequence on the aα chain of fibrinogen is essential for binding to its erythrocyte receptor10.2147/IJN.S154523 ↗
37. Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro
38. Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex10.1016/S0021-9258(19)85139-6 ↗
39. Evidence of a phospholipid binding species within human fibrinogen preparations10.1016/S0049-3848(99)00058-4 ↗
40. Carboxyl-terminal portions of the à chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated àC fragments on polymerization10.1016/S0021-9258(19)38688-0 ↗
41. Role of the aC domains of fibrin in clot formation10.1021/bi00188a031 ↗
42. Interactions mediated by the N-terminus of fibrinogen's bβ chain10.1021/bi061430q ↗
43. The structure and function of the aC domains of fibrinogen10.1111/j.1749-6632.2001.tb03517.x ↗
44. Direct interaction of fibrinogen with lipid microparticles modulates clotting kinetics and clot structure
45. Binding of fibrinogen to human monocytes10.1172/JCI112687 ↗
46. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen10.1083/jcb.107.5.1893 ↗
47. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet α-granules10.1172/JCI116170 ↗
48. The fate of dacron vascular grafts
49. Long-term behavior of a dacron arterial substitute: clinical, roentgenologic and histologic correlations10.1097/00000658-196509000-00015 ↗
50. Healing of arterial prostheses in man: its incompleteness10.1097/00000658-197201000-00018 ↗
51. Endothelium on the flow surface of human aortic Dacron vascular grafts10.1016/S0741-5214(97)70303-3 ↗